UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biallelic alterations in PLXND1 cause common arterial trunk and other cardiac malformations in humans

Human molecular genetics, 2023-01, Vol.32 (3), p.353-356

2023

Volltextzugriff (PDF)

Prognostic value of stem cell markers in glioblastoma

Biomarkers, 2019-10, Vol.24 (7), p.677-683

2019

Volltextzugriff (PDF)

Chronic pruritic warty papules on the buttocks

International journal of dermatology, 2018-06, Vol.57 (6), p.661-663

2018

Volltextzugriff (PDF)

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

Clinical cancer research, 2017-11, Vol.23 (22), p.7006-7019

2017

Volltextzugriff (PDF)

Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

Clinical cancer research, 2014-02, Vol.20 (4), p.938-950

2014

Volltextzugriff (PDF)

Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance

Oncotarget, 2015-04, Vol.6 (11), p.9284-9294

2015

Volltextzugriff (PDF)

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors

Breast cancer research : BCR, 2009-01, Vol.11 (2), p.402-402, Article 402

2009

Volltextzugriff (PDF)

Dysplastic nevus: the eye of the hurricane

Journal of cutaneous pathology, 2008-11, Vol.35 (s2), p.16-19

Arumi-Uria, Montserrat

2008

Volltextzugriff (PDF)

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

Cells (Basel, Switzerland), 2023-03, Vol.12 (6), p.843

2023

Volltextzugriff (PDF)

Versican Is Differentially Expressed in Human Melanoma and May Play a Role in Tumor Development

The American journal of pathology, 2002-02, Vol.160 (2), p.549-557

2002

Volltextzugriff (PDF)

Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

Cancers, 2022-05, Vol.14 (10), p.2393

2022

Volltextzugriff (PDF)

Voxel‐based morphometry for the evaluation of patients with pharmacoresistant epilepsy with apparently normal MRI

Journal of neuroimaging, 2021-05, Vol.31 (3), p.560-568

2021

Volltextzugriff (PDF)

Amyloid Beta-Peptide Increases BACE1 Translation through the Phosphorylation of the Eukaryotic Initiation Factor-2α

Oxidative medicine and cellular longevity, 2020, Vol.2020 (2020), p.1-12

2020

Volltextzugriff (PDF)

Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi

American journal of clinical pathology, 2003-04, Vol.119 (4), p.587-593

2003

Volltextzugriff (PDF)

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

Modern pathology, 2011-03, Vol.24 (3), p.443-452

2011

Volltextzugriff (PDF)

Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report

Journal of medical case reports, 2016-06, Vol.10 (1), p.158-158, Article 158

2016

Volltextzugriff (PDF)

C-MET as a new therapeutic target for the development of novel anticancer drugs

Clinical & translational oncology, 2010-04, Vol.12 (4), p.253-260

2010

Volltextzugriff (PDF)

Grading of Atypia in Nevi: Correlation with Melanoma Risk

Modern pathology, 2003-08, Vol.16 (8), p.764-771

2003

Volltextzugriff (PDF)

Eye screening service in primary care at Osona (Barcelona). Results (2002-05)

Atención primaria, 2007-08, Vol.39 (8), p.449-449

2007

Volltextzugriff (PDF)

Prognostic value of VEGFR2 immunoexpression in glioblastoma

Journal of solid tumors, 2019-10, Vol.10 (1), p.1

2019

Volltextzugriff (PDF)

Are ER+PR+ and ER+PR− breast tumors genetically different? A CGH array study

Cancer genetics, 2012-04, Vol.205 (4), p.138-146

2012

Volltextzugriff (PDF)

Are ER+PR+ and ER+PRa breast tumors genetically different? A CGH array study

Cancer genetics, 2012-04, Vol.205 (4), p.138-146

2012

Volltextzugriff (PDF)

Targeting the PI3K/AKT/mTOR pathway with MLN0128 (mTORC1/2 inh) and MLN1117 (PI3K alpha inh) in bladder cancer: Rational for its testing in clinical trials

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15520-e15520

2015

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)
Berichte
(1)

Sprache

Englisch
(44)
Spanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biallelic alterations in PLXND1 cause common arterial trunk and other cardiac malformations in humans

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Prognostic value of stem cell markers in glioblastoma

Chronic pruritic warty papules on the buttocks

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer

Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors

Dysplastic nevus: the eye of the hurricane

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

Versican Is Differentially Expressed in Human Melanoma and May Play a Role in Tumor Development

Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

Voxel‐based morphometry for the evaluation of patients with pharmacoresistant epilepsy with apparently normal MRI

Amyloid Beta-Peptide Increases BACE1 Translation through the Phosphorylation of the Eukaryotic Initiation Factor-2α

Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report

C-MET as a new therapeutic target for the development of novel anticancer drugs

Grading of Atypia in Nevi: Correlation with Melanoma Risk

Eye screening service in primary care at Osona (Barcelona). Results (2002-05)

Prognostic value of VEGFR2 immunoexpression in glioblastoma

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma

Are ER+PR+ and ER+PR− breast tumors genetically different? A CGH array study

Are ER+PR+ and ER+PRa breast tumors genetically different? A CGH array study

Targeting the PI3K/AKT/mTOR pathway with MLN0128 (mTORC1/2 inh) and MLN1117 (PI3K alpha inh) in bladder cancer: Rational for its testing in clinical trials

Suchergebnisse filtern